AB-CHMINACA

AB-CHMINACA

ab-chminaca spray for sale

To purchase AB-CHMINACA united kingdom, Europe in our  mymeds17.us  shop with fast global delivery! The pleasant AB-CHMINACA on the market you’ll find here!
AB-CHMINACA
Product Description
AB-CHMINACA on the market
AB-FUBINACA is an indazole-primarily based synthetic cannabinoid (CB) with 10-fold higher affinity referring to the principle CB1 receptor (Ki = 0.9 nM) in evaluation to JWH 018 .
AB-FUBINACA became first of all synthesized by way of Pfizer, Inc. as an powerful effective CB1 receptor modulator for viable healing usage, but no longer too long in the past had been discovered together with AB-PINACA in prohibited herbal merchandise.
AB-CHMINACA is structurally applicable to AB-FUBINACA which incorporates a cyclohexyl institution replaced for the 4-fluorophenyl institution. The bodily and toxicological attributes related to the substance haven’t been recognized. The product changed into created for research and forensic purposes.
This nice studies chemical in our laboratory. we can make sure you that while you order from us you will get a excessive purity studies chemical to your studies purspose.
This studies chemical is not meant for human intake. This cannabinoid ship direct from our lab to any usa in the international.
Dosage
Presumes no tolerance
Threshold < 1 mg Light 1 – 2 mg
Common 1 – 3 mg
Strong 4 – 5 mg
Heavy > five mg
length
general 1 – 2 hours
Onset 0 – 20 mins
peak 30 – 60 mins
Offset 10 – 20 mins
Afterglow 15 – 30 minutes
AB-CHMINACA is an indazole-primarily based synthetic cannabinoid. it’s far a robust agonist of the CB₁ receptor and CB₂ receptor and fully substitutes for Δ⁹-THC in rat discrimination studies, while being 16x more potent
AB-CHMINACA is an indazole-based artificial cannabinoid. it’s miles a effective agonist of the CB₁ receptor and CB₂ receptor and fully substitutes for Δ⁹-THC in rat discrimination studies, even as being 16x more potent
AB-CHMINACA is structurally applicable to AB-FUBINACA which incorporates a cyclohexyl institution replaced for the four-fluorophenyl institution. The bodily and toxicological attributes associated with the substance haven’t been identified. The product was created for studies and forensic purposes.